CMS Directors Urge Industry To Weigh In On MCIT Innovative Tech Proposal
Rule would supply direct reimbursement pathway for FDA breakthrough devices
Executive Summary
Medicare agency reimbursement experts asked device technology firms to explain regulatory hurdles to getting proper reimbursements for their products in comments on an innovative technology rule.